BioSpace News Archive

Oral Chemotherapy Market banking on Regulatory Approvals of New Drug Candidates

Fact.MR, Rockville MD: An ongoing study on the oral chemotherapy market by consulting firm Fact.MR anticipates a healthy growth outlook for FY 2021-22 and beyond, as global incidence of cancers across key regions increase at an alarming pace.

March 29, 2021
·
6 min read
Artificial Cornea Implant Market: Increasing cases of corneal eye disease across the globe to drive the market

The global artificial cornea implant market is likely to expand in the near future. This is mainly because of the increasing cases of corneal eye disease across the globe.

March 29, 2021
·
4 min read
Cat Allergy Therapeutics Market: Rise in Prevalence of Cat Allergies in People to Drive the Market

Cat allergy is an allergic reaction in humans to the allergens produced by cats. The most common cat allergen types are Fel d1 and Fel d4.

March 29, 2021
·
5 min read
Intravenous Solution Market: Increase in Demand for Intravenous Solutions to Drive the Market

Intravenous solutions are routinely used in clinical medicine for the replacement and maintenance of body fluids. They are administered to individuals with depletion of body fluids due to dehydration and other medical conditions.

March 29, 2021
·
5 min read
Micro-hospitals Market: Increased adoption of high-performance technologies to drive the market

The hospitals have extensive activity region and size of activity when contrasted with walking focuses and crisis care focuses.

March 29, 2021
·
3 min read
Retinal Drugs and Biologics Market: Increasing incidence of retinal disorder to drive the market

Human eyes are highly delicate and can be affected with the minutest of the things. Therefore, it security is of high importance.

March 29, 2021
·
4 min read
Fibromyalgia Market - North America Continues to Dominate the Market | TMR Research Study

Fibromyalgia also called Fibrositis, is a chronic pain disorder causing a widespread pain and tenderness to touch. Fibromyalgia affects people physically, mentally and socially.

March 29, 2021
·
7 min read
Plaquenil Drugs Market is expected to grow at a CAGR between 6-9% by 2031

Plaquenil drug, brand name of Hydroxychloroquine, is a disease modifying anti-rheumatic drug. It eases the pain and swelling of arthritis.

March 29, 2021
·
4 min read
Drug Development

NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19

NeuroRx, Inc. reports 60-day results of the Phase 2b/3 trial of intravenously-administered ZYESAMI™ for the treatment of respiratory failure in critically-ill patients with COVID-19, which is being developed in collaboration with Relief Therapeutics Holding AG.

March 29, 2021
·
11 min read
Business

Jacobio Pharma Announces CNY486 Million Revenue for 2020 Annual Results

Jacobio Pharmaceuticals announces its first annual results after its IPO. Revenue was CNY486 million; R&D costs exceeded CNY230 million, increasing 66% year-on-year.

March 29, 2021
·
2 min read